Clover Health Investments
CLOV
159 hedge funds and large institutions have $231M invested in Clover Health Investments in 2024 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 36 increasing their positions, 32 reducing their positions, and 23 closing their positions.
157% more capital invested
Capital invested by funds: $90.1M → $231M (+$141M)
139% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 23
124% more call options, than puts
Call options by funds: $20.7M | Put options by funds: $9.28M
25% more funds holding
Funds holding: 127 → 159 (+32)
13% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 32
2.12% more ownership
Funds ownership: 18% → 20.12% (+2.1%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.24M |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$3.35M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$3.12M |
| 4 |
Renaissance Technologies
New York
|
+$2.76M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.99M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$3.46M |
| 2 |
Jane Street
New York
|
-$2.07M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.27M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.21M |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$932K |
CLOV Hedge Fund Activity: Q3 2024 in Review
159 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q3 2024, worth a combined $231M — up 157% from $90.1M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new CLOV positions and 23 closed out — a net gain of 32 holders — while 36 added to existing stakes and 32 trimmed.
The largest buyer was Vanguard Group, adding an estimated $4.24M. The largest seller was Citadel Advisors, cutting an estimated $3.46M.
- 159 institutional investors held Clover Health Investments (CLOV) as of Q3 2024, up from 127 in Q2 2024.
- Funds reported $231M of Clover Health Investments stock for Q3 2024, up 157% quarter-over-quarter.
- 55 funds opened new Clover Health Investments positions in Q3 2024 and 23 closed out, a net change of +32 holders.
- The largest Clover Health Investments buyer in Q3 2024 was Vanguard Group, an estimated $4.24M added.
- The largest Clover Health Investments seller in Q3 2024 was Citadel Advisors, an estimated $3.46M sold.
Based on aggregated 13F filings for Q3 2024.